Label: AFRIN ORIGINAL- oxymetazoline hydrochloride spray
-
NDC Code(s):
11523-1167-1,
11523-1167-2,
11523-1167-3,
11523-1167-4, view more11523-1167-5, 11523-1167-6
- Packager: Bayer HealthCare LLC.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated November 15, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredient
- Purpose
- Uses
-
Warnings
Ask a doctor before use if you have
- heart disease
- high blood pressure
- diabetes
- thyroid disease
- trouble urinating due to an enlarged prostate gland
When using this product
- do not use more than directed
- do not use for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen.
- temporary discomfort such as burning, stinging, sneezing or an increase in nasal discharge may occur
- use of this container by more than one person may spread infection
-
Directions
- adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.
- children under 6 years of age: ask a doctor.
To spray, squeeze bottle quickly and firmly. Do not tilt head backward while spraying. Wipe nozzle clean after use.
- Other information
- Inactive ingredients
- Questions or comments?
- PRINCIPAL DISPLAY PANEL - 15 mL Bottle Carton
-
INGREDIENTS AND APPEARANCE
AFRIN ORIGINAL
oxymetazoline hydrochloride sprayProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:11523-1167 Route of Administration NASAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OXYMETAZOLINE HYDROCHLORIDE (UNII: K89MJ0S5VY) (OXYMETAZOLINE - UNII:8VLN5B44ZY) OXYMETAZOLINE HYDROCHLORIDE 0.05 g in 100 mL Inactive Ingredients Ingredient Name Strength SODIUM PHOSPHATE, DIBASIC (UNII: GR686LBA74) SODIUM PHOSPHATE, MONOBASIC (UNII: 3980JIH2SW) EDETATE DISODIUM (UNII: 7FLD91C86K) BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) POVIDONE (UNII: FZ989GH94E) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:11523-1167-2 2 in 1 CARTON 07/14/1975 1 21 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product 2 NDC:11523-1167-3 1 in 1 CARTON 07/14/1975 2 20 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product 3 NDC:11523-1167-4 3 in 1 CARTON 07/14/1975 3 30 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product 4 NDC:11523-1167-5 1 in 1 CARTON 07/14/1975 4 30 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product 5 NDC:11523-1167-6 1 in 1 CARTON 07/14/1975 5 15 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product 6 NDC:11523-1167-1 6 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product 11/16/2022 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M012 07/14/1975 Labeler - Bayer HealthCare LLC. (112117283)